Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

Overview of attention for article published in Frontiers in oncology, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells

Article in Science Translational Medicine (April 2024)

Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings

Article in Radiology Case Reports (March 2024)

Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature

Article in Insights into Imaging (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.